Myriad Genetics’ Post

Always great to talk to Jeff about the vision and journey of CancerLinQ®, founded by American Society of Clinical Oncology (ASCO) and now an initiative of ConcertAI - Robert Miller https://lnkd.in/dDfy7nP3 #oncodaily #oncology #cancer #technology #data #AI #precisiononcology #RWD #CancerResearch #oncologydata

🌍 Join us for our International Monthly Webinar on July 18th at 2 pm EST, featuring Kelly M. Brunk, PharmD, MBA(c), BCOP (NCODA), Kirollos Hanna, PharmD, BCPS, BCOP, FACCC (Minnesota Oncology), and Jeanine Ewing, PharmD, BCOP (Florida Cancer Specialists & Research Institute). Gain insights into the Sarclisa 1q21 gain/amplification PQI, explore findings from a survey on optimizing the implementation of new therapies in multiple myeloma to enhance patient care, and dive into the latest multiple myeloma research that was shared during ASCO 2024. Learn more and join at the link below:  https://lnkd.in/eyeGJdGW

Which Studies at ASCO 2024 May Change Practice? Emerging research from the 2024 ASCO Annual Meeting highlights critical findings in lung and blood cancers, emphasizing the potential for practice-changing results and the growing role of artificial intelligence in oncology. https://lnkd.in/eqR5-Yiq

Dr. Raj Madabushi of FDA summarizes the recurring themes and key points discussed during Day 1 of the American Association for Cancer Research-FDA workshop on Dose Optimization in Oncology Trials. Looking fwd ro attending tomorrow's sessions!

We highlight the overuse of terms such as 'tolerable', 'manageable' and 'acceptable' in reports of clinical trials - Edward Cliff oncodaily.com/20876.html #oncodaily #oncology #cancer #JAMA #research

Join us for the next webinar on July 2nd at 1pm ET: Understanding Your Melanoma Diagnosis. Dr. Govind Warrier, Assistant Professor of Oncology with Johns Hopkins Melanoma Program, and Cheryl Stratos will present a conversational approach to helping you understand your Melanoma diagnosis. Understanding your diagnosis is key to determining the best treatment path.

🗓️ Add this to your calendars! You won’t want to miss NCI’s session on Survivorship in Advanced Lung Cancer on June 3 at the American Society of Clinical Oncology (ASCO)'s annual meeting! In this session, you'll hear about how to address the needs of patients who are commonly excluded from clinical trials due to factors such as age and health issues. http://spr.ly/6040eIfgA #ASCO24 #CancerResearch #LCSM

Reflecting on the incredible sessions and panels at #ESMOGI24, I feel more equipped than ever to tackle the challenges in GI oncology. It was an honor to exchange ideas with the best in the field and witness groundbreaking research unveiling. Here's to transforming insights into impact and forming all the new partnerships. Together, we're moving closer to a world without cancer. #RocheOncology"

Reflecting on the incredible sessions and panels at #ESMOGI24, I feel more equipped than ever to tackle the challenges in GI oncology. It was an honor to exchange ideas with the best in the field and witness groundbreaking research unveiling. Here's to transforming insights into impact and forming all the new partnerships. Together, we're moving closer to a world without cancer. #RocheOncology"

🎙In episode 2 of Oncology Update, John Marshall, MD gives a wrap-up of ASCO 2024 and takes a deep dive into the costs of cancer care and more! Stay informed ➡ Watch the full video here: https://bit.ly/3KH2Dn0